Literature DB >> 9620220

Effect of glutathione-modulating compounds on hydrogen-peroxide-induced cytotoxicity in human glioblastoma and glioma cell lines.

M Iida1, S Sunaga, N Hirota, N Kuribayashi, H Sakagami, M Takeda, K Matsumoto.   

Abstract

The relation between the intracellular glutathione (GSH) concentration and hydrogen-peroxide(H2O2)-induced cytotoxicity was investigated. The intracellular GSH concentration in human glioblastoma (T98G, U87MG) and glioma (KG1C) cell lines was one or two orders of magnitude higher than that in a human myelogenous leukemic cell line (HL-60), which showed higher sensitivity to H2O2. Pretreatment of these cell lines with L-buthionine-[S,R]-sulfoximine, which significantly reduced the intracellular GSH concentration, increased their sensitivity against H2O2, whereas pretreatment with N-acetyl-L-cysteine, which did not significantly change the intracellular GSH concentration, only marginally protected the cells from the cytotoxic effect of H2O2. The results suggest that drug sensitivity of tumor cells can be modified by glutathione-modulating compounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9620220     DOI: 10.1007/s004320050115

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  6 in total

1.  Comparison of UVC Sensitivity and Dectin-2 Expression Between Malignant and Non-malignant Cells.

Authors:  Ayaka Shindo; Midori Kusano; Hiroshi Sakagami; Shigeru Amano; Megumi Inomata; Masayo Abe; Masashi Okazawa; Takafumi Ooka
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 2.  A role for glutamate in growth and invasion of primary brain tumors.

Authors:  Harald Sontheimer
Journal:  J Neurochem       Date:  2008-02-14       Impact factor: 5.372

Review 3.  Ion channels and amino acid transporters support the growth and invasion of primary brain tumors.

Authors:  Harald Sontheimer
Journal:  Mol Neurobiol       Date:  2004-02       Impact factor: 5.590

4.  High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.

Authors:  Ajit G Thomas; Rita Sattler; Karen Tendyke; Kara A Loiacono; Hans Hansen; Vishal Sahni; Yutaka Hashizume; Camilo Rojas; Barbara S Slusher
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 5.  Role of Redox Status in Development of Glioblastoma.

Authors:  Aleli Salazar-Ramiro; Daniela Ramírez-Ortega; Verónica Pérez de la Cruz; Norma Y Hérnandez-Pedro; Dinora Fabiola González-Esquivel; Julio Sotelo; Benjamín Pineda
Journal:  Front Immunol       Date:  2016-04-26       Impact factor: 7.561

6.  Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma.

Authors:  Alessia Lo Dico; Daniela Salvatore; Cristina Martelli; Dario Ronchi; Cecilia Diceglie; Giovanni Lucignani; Luisa Ottobrini
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.